Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Zillow Group Inc Class A — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Zillow Group Inc Class A trades at $29.53 (market cap $6.33B). The key difference: Ionis Pharmaceuticals Inc. Common Stock and Zillow Group Inc Class A are close in size by market cap, and Ionis Pharmaceuticals Inc. Common Stock is more actively traded (2,977,440 versus 1,202,678). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Zillow Group Inc Class A for 86 Days on average.
| IONS | ZG | |
|---|---|---|
Market Cap | $7.04B | $6.33B |
Volume | 2,977,440 | 1,202,678 |
Sector | Health | Media |
52-Week High | $86.50 | $74.58 |
52-Week Low | $42.38 | $27.70 |
Typical Hold Time | 0 Days | 86 Days |
Enterprise Value | $6.60B | $6.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (ZG) trades at $29.27, up 2.02% today, amid a challenging housing market. The stock is technically bearish, trading near its pivot point of $29, with key resistance at $30 and support at $28. Fundamentally, the company has returned to profitability in 2025 with a net income of $23 million, a significant improvement from prior years' losses, though its P/E ratio of 125.43 remains high. Recent news highlights competitive pressures and interest rate sensitivity.
The outlook is mixed. Analyst consensus is a 'Hold' with a $48.60 price target, implying substantial upside, but execution on its integrated transaction platform and navigating housing affordability headwinds are key. Risks include market volatility and a high valuation. The path to sustained profitability will be the primary driver for the stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
